Literature DB >> 33093855

Cytologic studies of in vivo fallopian tube specimens in patients undergoing salpingo-oophorectomy.

Sharmila Pramanik1, Eric Yang2, Wendy Wu1.   

Abstract

OBJECTIVES: Recent research shows that most high grade ovarian cancer (OC) originates from the fallopian tube (FT). Cytologic evaluation of FT cells may enable early detection of OC.
MATERIAL AND METHODS: This was a prospective study with patients enrolled from 3 centers (October 2016- August 2017). Forty-two women undergoing salpingo-oophorectomy for a pelvic mass suspicious for malignancy or undergoing risk-reducing surgery for BRCA mutations were included in the study. At the time of scheduled surgery, a novel catheter was used to collect FT cells through hysteroscopy. A pathologist blinded to surgical or pathologic findings evaluated FT cytology, and results were compared to pathology.
RESULTS: Of the 61 samples collected, 72% (44/61) met the adequacy criteria (≥5 clusters of cells with 20 cells in each cluster). Cytology classification criteria were established and applied to adequate samples. Forty-four samples were benign with mixed population of cells with round, oval, and spindled nuclei; 2-dimensional clusters; columnar cell configuration; flat sheets; cilia presence; no/mild nuclear pleomorphism; no nuclear membrane irregularities; and no nucleoli. Five samples had benign features with reactive nuclear and cytoplasmic changes and/or background inflammation, which were categorized as "reactive atypia." Two malignant samples had features of 3-dimensional (3D) clusters, loss of mixed population of cells; increased nuclear/cytoplasmic ratio; nuclear membrane irregularity and nucleoli presence. Three samples with some but not all of malignant features were categorized as "neoplastic" (anisonucleosis; small nucleoli and features suggestive of 3D clusters). Malignant/ neoplastic samples were labeled as "Positive" (n = 5) while benign/reactive samples were labeled as "Negative" (n = 39). A high concordance rate (95%, 42/44) was observed between cytology results and histology.
CONCLUSIONS: We characterized cytologic features for pathologically distinct FT samples collected in vivo using a novel catheter and demonstrated its value in detecting OC. ©2020 Cytopathology Foundation Inc, Published by Scientific Scholar.

Entities:  

Keywords:  BRCA; Cytuity; Detection; Hysteroscopy; Ovarian cancer

Year:  2020        PMID: 33093855      PMCID: PMC7568227          DOI: 10.25259/CytoJournal_7_2020

Source DB:  PubMed          Journal:  Cytojournal        ISSN: 1742-6413            Impact factor:   2.091


  18 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 2.  The role of the fallopian tube in the origin of ovarian cancer.

Authors:  Britt K Erickson; Michael G Conner; Charles N Landen
Journal:  Am J Obstet Gynecol       Date:  2013-04-10       Impact factor: 8.661

3.  Tubal origin of 'ovarian' low-grade serous carcinoma.

Authors:  Jie Li; Nisreen Abushahin; Shujie Pang; Li Xiang; Setsuko K Chambers; Oluwole Fadare; Beihua Kong; Wenxin Zheng
Journal:  Mod Pathol       Date:  2011-06-24       Impact factor: 7.842

Review 4.  Molecular pathogenesis of endometrial and ovarian cancer.

Authors:  Melissa A Merritt; Daniel W Cramer
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

5.  Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.

Authors: 
Journal:  Obstet Gynecol       Date:  2017-09       Impact factor: 7.661

Review 6.  SGO White Paper on ovarian cancer: etiology, screening and surveillance.

Authors:  John O Schorge; Susan C Modesitt; Robert L Coleman; David E Cohn; Noah D Kauff; Linda R Duska; Thomas J Herzog
Journal:  Gynecol Oncol       Date:  2010-08-07       Impact factor: 5.482

Review 7.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

Review 8.  Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

Authors:  Russell Vang; Ie-Ming Shih; Robert J Kurman
Journal:  Histopathology       Date:  2013-01       Impact factor: 5.087

9.  Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  David C Grossman; Susan J Curry; Douglas K Owens; Michael J Barry; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Maureen G Phipps; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng
Journal:  JAMA       Date:  2018-02-13       Impact factor: 56.272

10.  Cytology of the fallopian tube: A screening model for high-grade serous carcinoma.

Authors:  Maya Dhanani; Aziza Nassar; Mélissa S Charles; Tri Dinh
Journal:  Cytojournal       Date:  2018-11-12       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.